ArticleJournal of pain research2025
A Retrospective Study of Ultrasound-Guided C2 Transverse Process Injection with Myofascial Release for Cervicogenic Headache.
Article in Journal of pain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the efficacy and safety of ultrasound-guided myofascial hydrodissection between the obliquus capitis inferior and semispinalis capitis muscles combined with C2 transverse process injection in patients with cervicogenic headache (CGH). Methods: This retrospective study analyzed 80 patients with CGH who received four sessions of ultrasound-guided treatment from January to December 2024. Each session consisted of hydrodissection of the obliquus capitis inferior and semispinalis capitis muscles along with C2 transverse process injections of lidocaine and corticosteroids. Pain intensity, disability, and headache impact were assessed using the numeric rating scale (NRS), neck disability index (NDI), and headache impact test-6 (HIT-6) at baseline, 1 week, 1 month, 3 months, and 6 months. Results: All patients completed the treatment without serious complications. Notable and consistent reductions in NRS, NDI, and HIT-6 scores were observed at all follow-up points (P < 0.05). Minor transient adverse events, including dizziness and mild discomfort, resolved spontaneously. Conclusion: This retrospective study suggests that ultrasound-guided myofascial hydrodissection combined with C2 transverse process injection may provide potentially meaningful pain relief and functional improvement in patients with CGH. However, given the uncontrolled retrospective design, the findings should be interpreted with caution and require confirmation in prospective controlled trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.